|
Symbol
|
RLLAEV | FBGAJB | RLLABV | COMBKB | LACTDU | RLLACV | RLLADV | RLLAIV | RLLAAV |
|---|---|---|---|---|---|---|---|---|---|
| Nom | Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. | Eli Lilly & Co. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
15.09.2026 | 26.03.2026 | 16.12.2025 | 24.08.2026 | 15.05.2026 | 27.07.2026 | 31.07.2026 | 17.08.2026 | 18.11.2026 |
| Ratio | 0,902706 | 0,91504 | 0,811109 | - | 0,776699 | 0,770078 | 0,804059 | 0,649051 | 0,970403 |
|
Prix d'exercise
|
- | - | - | - | - | - | - | - | - |
| rendement max. p.a. | 7,33% | 8,46% | - | - | 5,43% | 5,37% | 7,34% | 3,73% | 9,30% |
| Demande | 100,10 | - | 100,00 | - | 100,80 | 101,50 | - | 102,20 | - |
| Offre | 101,50 | - | 100,40 | - | 101,80 | 102,90 | - | 103,60 | - |